Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.

Clinical trial NCT06975605 · COMPLETED

Trial details

NCT number: NCT06975605
Sponsor: GRIN Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Tuberous Sclerosis Complex (TSC)Focal Cortical Dysplasia Other Neurological Disorders

Start date: 2025-05-20
Primary completion: 2025-07-10
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.